We are live on ! Find out more
EFU icon

ProShares Trust UltraShort MSCI EAFE

1 hedge funds and large institutions have $9 invested in ProShares Trust UltraShort MSCI EAFE in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 21 (-1)

57% less capital invested

Capital invested by funds: $21 → $9 (-$12)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$12
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
1
UBS Group
Switzerland
$9
Morgan Stanley
2
Morgan Stanley
New York
-$12 -1 Closed

EFU Hedge Fund Activity: Q1 2026 in Review

1 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in ProShares Trust UltraShort MSCI EAFE (EFU) for Q1 2026, worth a combined $9 — down 57% from $21 a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of EFU and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Morgan Stanley, exiting entirely with an estimated $12 sold.

  • 1 institutional investor held ProShares Trust UltraShort MSCI EAFE (EFU) as of Q1 2026, down from 2 in Q4 2025.
  • Funds reported $9 of ProShares Trust UltraShort MSCI EAFE stock for Q1 2026, down 57% quarter-over-quarter.
  • 0 funds opened new ProShares Trust UltraShort MSCI EAFE positions in Q1 2026 and 1 closed out, a net change of -1 holder.
  • The largest ProShares Trust UltraShort MSCI EAFE seller in Q1 2026 was Morgan Stanley, an estimated $12 sold.

Based on aggregated 13F filings for Q1 2026.